Modular Medical operates as a drug delivery tech developer.
Modular Medical, Inc. is a development-stage, insulin delivery company. The Company's founder, CEO and lead stockholder is Paul DiPerna, who was the previous founder and chief technical officer of Tandem Diabetes Care. Mr. DiPerna's vision is that the leading insulin pump companies are too focused on "superusers," people with diabetes with the time, motivation and resources to utilize complex, expensive products. As a result, these entities have largely neglected the approximately one million people in the United States who still rely on daily injections for treatment. Modular seeks to expand the insulin delivery marketplace to these underserved patients, so they can benefit from Modular's advanced technology to assist in their care.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 12, 2021 | Post-IPO Debt | $6.60M | — | — | — | Detail |
Feb 18, 2021 | IPO | — | — | — | — | Detail |
Apr 5, 2019 | Series Unknown | $4.17M | — | — | — | Detail |
Mar 1, 2017 | Funding Round | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Varana Capital | — | Funding Round |